Lifibrol: first member of a new class of lipid-lowering drugs?

Hubert Scharnagl (First author)
, Winfried März
, H Wieland

Medical University Graz

Research output: Contribution to journal › Research article

Original language	English
Journal	Expert Opinion on Investigational Drugs
DOIs	https://doi.org/10.1517/13543784.6.5.583
Publication status	Published - 1997

Branches of science

302 Clinical Medicine
301 Medical-Theoretical Sciences, Pharmacy
104 Chemistry

DOI

10.1517/13543784.6.5.583

Links

PubMed

Cite this

@article{c4534183d35f465cb018392dadecba83,

title = "Lifibrol: first member of a new class of lipid-lowering drugs?",

author = "Hubert Scharnagl and Winfried M{\"a}rz and H Wieland",

year = "1997",

doi = "10.1517/13543784.6.5.583",

language = "English",

journal = "Expert Opinion on Investigational Drugs",

issn = "1354-3784",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Lifibrol: first member of a new class of lipid-lowering drugs?

AU - März, Winfried

AU - Wieland, H

A2 - Scharnagl, Hubert

PY - 1997

Y1 - 1997

UR - https://pubmed.ncbi.nlm.nih.gov/15989622

U2 - 10.1517/13543784.6.5.583

DO - 10.1517/13543784.6.5.583

M3 - Research article

C2 - 15989622

SN - 1354-3784

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

ER -